Загрузка...
Hepatocellular Carcinoma Recurrence in HCV Patients Treated with Direct Antiviral Agents
The risk of hepatocellular carcinoma recurrence is universal regardless of the treatment modality applied, and secondary prevention is still an unmet issue even though the elimination of hepatitis C (HCV) with direct antiviral agents (DAAs) was expected to be one of the new options. Unfortunately, t...
Сохранить в:
| Опубликовано в: : | Viruses |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6563506/ https://ncbi.nlm.nih.gov/pubmed/31052463 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v11050406 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|